Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10158214 | Medical Hypotheses | 2018 | 6 Pages |
Abstract
Incidence of patients suffering from therapy resistant CRPS-I referred for amputation is low and because referred patients are strongly in favor of an amputation, a randomized controlled trial will be difficult to perform. Hence level of evidence in favor or against an amputation will remain low. We therefore report our decision making process to facilitate discussion about this difficult and delicate matter.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
E. Schrier, P.U. Dijkstra, C.J. Zeebregts, A.P. Wolff, J.H.B. Geertzen,